Literature DB >> 17855756

Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy.

Giuseppe D'Antona1, Lorenza Brocca, Orietta Pansarasa, Chiara Rinaldi, Rossella Tupler, Roberto Bottinelli.   

Abstract

We recently generated a mouse model of facioscapulohumeral muscular dystrophy (FSHD) by selectively overexpressing FRG1, a candidate gene for FSHD, in skeletal muscle. The muscles of the FRG-1 mice did not show any plasmamembrane defect suggesting a novel pathogenetic mechanism for FSHD. Here, we study structure and function of muscle fibres from three lines of mice overexpressing FRG1 at different levels: FRG1-low, FRG1-med, FRG1-high. Cross-sectional area (CSA), specific force (Po/CSA) and maximum shortening velocity (V(o)) of identified types of muscle fibres from FRG1-low and FRG1-med mice were analysed and found to be lower than in WT mice. Fast fibres and especially type 2B fibres (the fastest type) were preferentially involved in the dystrophic process showing a much larger force deficit than type 1 (slow) fibres. Consistent with the latter observation, the MHC isoform distribution of several muscles of the three FRG1 lines showed a shift towards slower MHC isoforms in comparison to WT muscle. Moreover, fast muscles showed a more evident histological deterioration, a larger atrophy and a higher percentage of centrally nucleated fibres than the soleus, the slowest muscle in mice. Interestingly, loss in CSA, Po/CSA and V(o) of single muscle fibres and MHC isoform shift towards a slower phenotype can be considered early signs of muscular dystrophy (MD). They were, in fact, found also in FRG1-low mice which did not show any impairment of function in vivo and of muscle size in vitro and in soleus muscles, which had a completely preserved morphology. This study provides a detailed characterization of structure and function of muscle fibres in a novel murine model of one of the main human MDs and suggests that fundamental features of the dystrophic process, common to most MDs, such as the intrinsic loss of contractile strength of muscle fibres, the preferential involvement of fast fibres and the shift towards a slow muscle phenotype can occur independently from obvious alterations of the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855756      PMCID: PMC2277004          DOI: 10.1113/jphysiol.2007.141481

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  57 in total

Review 1.  Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: role of ionic changes.

Authors:  D G Allen; N P Whitehead; E W Yeung
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

2.  Whole-muscle and single-fibre contractile properties and myosin heavy chain isoforms in humans.

Authors:  S D Harridge; R Bottinelli; M Canepari; M A Pellegrino; C Reggiani; M Esbjörnsson; B Saltin
Journal:  Pflugers Arch       Date:  1996-09       Impact factor: 3.657

3.  Force-velocity properties of human skeletal muscle fibres: myosin heavy chain isoform and temperature dependence.

Authors:  R Bottinelli; M Canepari; M A Pellegrino; C Reggiani
Journal:  J Physiol       Date:  1996-09-01       Impact factor: 5.182

4.  Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse.

Authors:  Ella W Yeung; Nicholas P Whitehead; Thomas M Suchyna; Philip A Gottlieb; Frederick Sachs; David G Allen
Journal:  J Physiol       Date:  2004-11-04       Impact factor: 5.182

Review 5.  Pathophysiology of duchenne muscular dystrophy: current hypotheses.

Authors:  Nicolas Deconinck; Bernard Dan
Journal:  Pediatr Neurol       Date:  2007-01       Impact factor: 3.372

6.  Muscle regeneration by bone marrow-derived myogenic progenitors.

Authors:  G Ferrari; G Cusella-De Angelis; M Coletta; E Paolucci; A Stornaiuolo; G Cossu; F Mavilio
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

7.  Unloaded shortening velocity and myosin heavy chain and alkali light chain isoform composition in rat skeletal muscle fibres.

Authors:  R Bottinelli; R Betto; S Schiaffino; C Reggiani
Journal:  J Physiol       Date:  1994-07-15       Impact factor: 5.182

8.  Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice.

Authors:  D A Williams; S I Head; G S Lynch; D G Stephenson
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

9.  Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch.

Authors:  P Moens; P H Baatsen; G Maréchal
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

10.  Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy.

Authors:  P Bonaldo; P Braghetta; M Zanetti; S Piccolo; D Volpin; G M Bressan
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

View more
  10 in total

1.  Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy.

Authors:  Radbod Darabi; June Baik; Mark Clee; Michael Kyba; Rossella Tupler; Rita C R Perlingeiro
Journal:  Exp Neurol       Date:  2009-08-13       Impact factor: 5.330

2.  Increased resistance towards fatigability in patients with facioscapulohumeral muscular dystrophy.

Authors:  Matteo Beretta-Piccoli; Luca Calanni; Massimo Negro; Giulia Ricci; Cinzia Bettio; Marco Barbero; Angela Berardinelli; Gabriele Siciliano; Rossella Tupler; Emiliano Soldini; Corrado Cescon; Giuseppe D'Antona
Journal:  Eur J Appl Physiol       Date:  2021-03-01       Impact factor: 3.078

3.  Decreased proliferation kinetics of mouse myoblasts overexpressing FRG1.

Authors:  Steven C Chen; Ellie Frett; Joseph Marx; Darko Bosnakovski; Xylena Reed; Michael Kyba; Brian K Kennedy
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

4.  Direct interplay between two candidate genes in FSHD muscular dystrophy.

Authors:  Giulia Ferri; Claudia H Huichalaf; Roberta Caccia; Davide Gabellini
Journal:  Hum Mol Genet       Date:  2014-10-17       Impact factor: 6.150

Review 5.  Autonomic dysfunction in muscular dystrophy: a theoretical framework for muscle reflex involvement.

Authors:  Scott A Smith; Ryan M Downey; Jon W Williamson; Masaki Mizuno
Journal:  Front Physiol       Date:  2014-02-18       Impact factor: 4.566

Review 6.  Altered cross-bridge properties in skeletal muscle dystrophies.

Authors:  Aziz Guellich; Elisa Negroni; Valérie Decostre; Alexandre Demoule; Catherine Coirault
Journal:  Front Physiol       Date:  2014-10-14       Impact factor: 4.566

7.  Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model.

Authors:  Alberto Real-Martinez; Astrid Brull; Jordi Huerta; Guillermo Tarrasó; Alejandro Lucia; Miguel Angel Martin; Joaquin Arenas; Antoni L Andreu; Gisela Nogales-Gadea; John Vissing; Thomas O Krag; Noemi de Luna; Tomàs Pinós
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

8.  Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1).

Authors:  Valentina Sancisi; Elena Germinario; Alessandra Esposito; Elisabetta Morini; Samantha Peron; Maurizio Moggio; Giuliano Tomelleri; Daniela Danieli-Betto; Rossella Tupler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-04       Impact factor: 3.619

9.  Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model.

Authors:  Ngoc Lu-Nguyen; Alberto Malerba; Shan Herath; George Dickson; Linda Popplewell
Journal:  Hum Mol Genet       Date:  2021-07-09       Impact factor: 6.150

10.  Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy.

Authors:  Pamela Bella; Andrea Farini; Stefania Banfi; Daniele Parolini; Noemi Tonna; Mirella Meregalli; Marzia Belicchi; Silvia Erratico; Pasqualina D'Ursi; Fabio Bianco; Mariella Legato; Chiara Ruocco; Clementina Sitzia; Simone Sangiorgi; Chiara Villa; Giuseppe D'Antona; Luciano Milanesi; Enzo Nisoli; PierLuigi Mauri; Yvan Torrente
Journal:  EMBO Mol Med       Date:  2019-12-02       Impact factor: 12.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.